冠脉搭桥术后新发房颤对5年临床结局与费用的影响
该研究为VA「随机停跳/不停跳搭桥随访研究」的子分析,比较CABG术后新发房颤(POAF,n=551)与无POAF(n=1552)患者的5年结局与费用。结果发现,未校正的5年全因死亡和心源性死亡在POAF组更高,但风险校正后无显著差异;POAF组术后第一年费用更高,但第2至5年费用相似。
要点
- 风险校正后,POAF与无POAF患者5年全因死亡和心源性死亡无显著差异。
- POAF组术后第一年费用较无POAF组高15,300美元,但2至5年费用相似。
- 未校正时POAF组5年全因死亡(16.3% vs 11.9%)和心源性死亡(7.4% vs 4.8%)更高。
核心结论
- CABG术后新发POAF患者经风险校正后5年临床结局与无POAF患者无显著差异。
- POAF组术后第一年费用更高,但这一差异在后续年份未持续。
研究设计与样本
- 研究为VA「随机停跳/不停跳搭桥随访研究」的子分析,共纳入2203名退伍军人,排除术前房颤(93例)和数据缺失(7例)后,比较新发POAF(n=551)与无POAF(n=1552)患者。
- 比较未校正和风险校正的5年结局,包括死亡、主要不良心血管事件(MACE)、MACE组分、卒中和费用,统计显著性要求P≤.01。
主要发现
- 未校正5年全因死亡率POAF组16.3%,无POAF组11.9%,P=.008。
- 未校正5年心源性死亡率POAF组7.4%,无POAF组4.8%,P=.022。
- 未校正时其他结局包括MACE或卒中在两组间无差异。
- 风险校正后,5年全因死亡(POAF比值比1.19;99%CI 0.81-1.75)和心源性死亡(比值比1.51;99%CI 0.88-2.60)无显著差异。
- 风险校正后术后第一年费用POAF组高15,300美元,但第2至5年费用相似。
临床怎么用
- 对于CABG术后新发POAF患者,应关注术后第一年的费用管理,但长期临床结局风险校正后未见显著增加。
局限性
- 本研究为回顾性子分析,POAF组患者年龄更大且合并症更复杂,可能存在残余混杂。
- 统计显著性阈值设定为P≤.01,可能影响部分结果的解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The impact of new-onset postoperative atrial fibrillation (POAF) following coronary artery bypass grafting (CABG) surgery on long-term clinical outcomes and costs is not known. This subanalysis of the Veterans Affairs "Randomized On/Off Bypass Follow-up Study" compared 5-year outcomes and costs between patients with and without POAF. METHODS: Of the 2203 veterans in the study, 100 with pre-CABG atrial fibrillation (93) or missing data (7) were excluded (4.8%). Unadjusted and risk-adjusted outcomes were compared between new-onset POAF (n = 551) and patients without POAF (n = 1552). Five-year clinical outcomes included mortality, major adverse cardiovascular events (MACE, comprising mortality, repeat revascularization, and myocardial infarction), MACE subcomponents, stroke, and costs. A stringent P value of ≤.01 was required to identify statistical significance. RESULTS: Patients with POAF were older and had more complex comorbidities. Unadjusted 5-year all-cause mortality was 16.3% POAF versus 11.9% no-POAF, P = .008. Unadjusted cardiac-mortality was 7.4% versus 4.8%, P = .022. There were no differences between groups in any other unadjusted outcomes including MACE or stroke. After risk adjustment, there were no significant differences between groups in 5-year all-cause mortality (POAF odds ratio, 1.19; 99% confidence interval, 0.81-1.75) or cardiac mortality (odds ratio, 1.51, 99% confidence interval, 0.88-2.60). Adjusted first-year post-CABG costs were $15,300 greater for patients with POAF, but 2- through 5-year costs were similar. CONCLUSIONS: No 5-year risk-adjusted outcome differences were found between patients with and without POAF after CABG. Although first-year costs were greater in patients with POAF, this difference did not persist in subsequent years.
引用
- Almassi GH, Hawkins RB, Bishawi M, et al. New-onset postoperative atrial fibrillation impact on 5-year clinical outcomes and costs. J Thorac Cardiovasc Surg. 2019. PMID: 31866082. doi:10.1016/j.jtcvs.2019.10.150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。